Studii clinice pentru BPOC în Texas
25 studii pentru BPOC caută participanți în Texas.
Orașe în Texas
- Houston15 studii
- Dallas12 studii
- El Paso5 studii
- McKinney5 studii
- Cypress4 studii
- Mesquite4 studii
- Denison3 studii
- Sugar Land3 studii
- Grand Prairie3 studii
- Lewisville3 studii
- San Antonio3 studii
- The Woodlands3 studii
Text oficial al studiului (în engleză)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Abilene
- Research Site, Brownsville
- Research Site, Dallas
- și încă 12
În curs de recrutareFaza 3
Vârste de la 40 la 80 · Toate sexele · Actualizat 2 oct. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Solace Clinical Research- Site Number : 8400087, Austin
- IntraCare- Site Number : 8400034, Dallas
- Premier Pulmonary Critical Care and Sleep- Site Number : 8400111, Denison
- și încă 7
În curs de recrutareFaza 3
Vârste de la 40 la 80 · Toate sexele · Actualizat 1 oct. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Horizon Clinical Research Group., Cypress
- Metroplex Pulmonary and Sleep Center, McKinney
- DM Clinical Research- Tomball, Tomball
În curs de recrutareFaza 2
Vârste de la 40 la 85 · Toate sexele · Actualizat 30 sept. 2026 · NCT07684820A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50001, Boerne
În curs de recrutareFaza 2
Vârste de la 40 la 80 · Toate sexele · Actualizat 25 sept. 2026 · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Premier Pulmonary Critical Care and Sleep, Denison
- Baylor College of Medicine Medical Center, Houston
- Prime Clinical Research - Lewisville, Lewisville
În curs de recrutareFaza 2
Vârste de la 40 la 75 · Toate sexele · Actualizat 25 sept. 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Wellness Clinical Research - Allen- Site Number : 8400085, Allen
- REX Clinical Trials - Beaumont- Site Number : 8400014, Beaumont
- Novel Research - Bellaire- Site Number : 8400116, Bellaire
- și încă 17
În curs de recrutareFaza 3
Vârste de la 40 la 80 · Toate sexele · Actualizat 22 sept. 2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont
În curs de recrutareFaza 4
Vârste de la 40 la 85 · Toate sexele · Actualizat 22 sept. 2026 · NCT07053423An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- University of Texas Southwestern, Dallas
În curs de recrutare
Vârste de la 40 la 80 · Toate sexele · Actualizat 17 sept. 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, McKinney
- WB Contracted Clinical Research Site, Waxahachie
În curs de recrutareFaza 2
Vârste de la 40 la 80 · Toate sexele · Actualizat 15 sept. 2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Boerne
- Research Site, Dallas
- Research Site, Denison
- și încă 5
În curs de recrutareFaza 2
Vârste de 40 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Baylor College of Medicine, Houston
În curs de recrutareFaza 2
Vârste de 40 ani și peste · Toate sexele · Actualizat 4 sept. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Boerne
- Research Site, El Paso
- Research Site, Houston
- și încă 6
În curs de recrutareFaza 3
Vârste de la 40 la 80 · Toate sexele · Actualizat 3 sept. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Dallas
- Research Site, Forney
- Research Site, Fort Worth
- și încă 5
În curs de recrutareFaza 3
Vârste de la 40 la 80 · Toate sexele · Actualizat 3 sept. 2026 · NCT06883305The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- The Lung & Sleep Institute of North Texas, North Richland Hills
În curs de recrutareStudiu observațional
Vârste de 40 ani și peste · Toate sexele · Actualizat 1 sept. 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Ten20 Clinical Research, Carrollton
- Horizon Clinical Research Group, Cypress
- și încă 4
În curs de recrutareFaza 2/3
Vârste de la 35 la 80 · Toate sexele · Actualizat 31 aug. 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
În curs de recrutareFaza 3
Vârste de la 18 la 80 · Toate sexele · Actualizat 11 aug. 2026 · NCT07555483STRIVE Post-Market Registry Study
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
- University of Texas Health Science Center at Houston, Houston
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 3 aug. 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Dallas
- GSK Investigational Site, DeSoto
- GSK Investigational Site, Greenville
- și încă 6
În curs de recrutareFaza 3
Vârste de la 40 la 75 · Toate sexele · Actualizat 28 iul. 2026 · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 10 iul. 2026 · NCT05181826Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Houston Methodist/Primary Critical Care, Houston
În curs de recrutare
Vârste de la 40 la 84 · Toate sexele · Actualizat 24 apr. 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, El Paso
- și încă 5
În curs de recrutareFaza 3
Vârste de la 40 la 80 · Toate sexele · Actualizat 9 apr. 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Corsicana
În curs de recrutareFaza 3
Vârste de la 40 la 80 · Toate sexele · Actualizat 8 oct. 2025 · NCT06959095Interprofessional Pharmacogenomics (IPGx) Registry and Repository
- Texas A&M Family Care, Bryan
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 12 sept. 2025 · NCT06726590Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Horizon Clinical Research Group, Houston
- CHRISTUS Trinity Mother Frances Health System, Tyler
În curs de recrutareStudiu observațional
Vârste de 50 ani și peste · Toate sexele · Actualizat 5 aug. 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Respire Research Institute, Houston
În curs de recrutare
Vârste de 30 ani și peste · Toate sexele · Actualizat 6 feb. 2025 · NCT05204888Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.